Literature DB >> 15832360

Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism?

Muriel Girard1, Jeanne Amiel, Monique Fabre, Danièle Pariente, Stanislas Lyonnet, Emmanuel Jacquemin.   

Abstract

Adams-Oliver syndrome (AOS) is characterized by the association of scalp and skull defects and abnormalities of terminal limbs. Congenital heart malformations have also been reported. Hepatoportal sclerosis (HPS) is a rare cause of portal hypertension in children characterized by abnormalities of intra-hepatic portal veins, portal fibrosis, and nodular regeneration. Etiopathogenesis of these rare disorders remains unclear, but the hypothesis of vascular thrombotic mechanism has been suggested. Association of both syndromes has been reported in only one child. We now report on two unrelated children with AOS and HPS, one child harboring a factor V Leiden mutation. We hypothesize that the association of both disorders may not be fortuitous and reinforces the idea that AOS and HPS may share a vascular thrombotic mechanism. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15832360     DOI: 10.1002/ajmg.a.30724

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

Review 1.  Clinical characteristics of idiopathic portal hypertension.

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

Review 2.  Paediatric chronic liver diseases: how to investigate and follow up? Role of imaging in the diagnosis of fibrosis.

Authors:  Danièle Pariente; Stéphanie Franchi-Abella
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 3.  The current clinical aspects of idiopathic portal hypertension.

Authors:  Tomohiro Tanaka; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

Review 4.  Pathology of idiopathic non-cirrhotic portal hypertension.

Authors:  Maria Guido; Samantha Sarcognato; Diana Sacchi; Guido Colloredo
Journal:  Virchows Arch       Date:  2018-04-12       Impact factor: 4.064

5.  Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension.

Authors:  Kadim Bayan; Yekta Tüzün; Serif Yilmaz; Naime Canoruc; Mehmet Dursun
Journal:  J Thromb Thrombolysis       Date:  2008-08-07       Impact factor: 2.300

6.  Haploinsufficiency of the NOTCH1 Receptor as a Cause of Adams-Oliver Syndrome With Variable Cardiac Anomalies.

Authors:  Rajiv D Machado; Richard C Trembath; Laura Southgate; Maja Sukalo; Anastasios S V Karountzos; Edward J Taylor; Claire S Collinson; Deborah Ruddy; Katie M Snape; Bruno Dallapiccola; John L Tolmie; Shelagh Joss; Francesco Brancati; M Cristina Digilio; Luitgard M Graul-Neumann; Leonardo Salviati; Wiltrud Coerdt; Emmanuel Jacquemin; Wim Wuyts; Martin Zenker
Journal:  Circ Cardiovasc Genet       Date:  2015-05-11

Review 7.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.

Authors:  Michel Kmeid; Xiuli Liu; Samuel Ballentine; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2021-04-21

Review 8.  Idiopathic non-cirrhotic portal hypertension: a review.

Authors:  Jeoffrey N L Schouten; Joanne Verheij; Susana Seijo
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123

9.  Bone morphogenetic protein receptor 2 in patients with idiopathic portal hypertension.

Authors:  Andrea De Gottardi; Susana Seijo; Montserrat Milá; M Isabel Alvarez; Miquel Bruguera; Juan G Abraldes; Jaime Bosch; Juan-Carlos García-Pagán
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

10.  Hepatoportal sclerosis in childhood: descriptive analysis of 12 patients.

Authors:  Mustafa Serdar Cantez; Nelgin Gerenli; Vildan Ertekin; Mine Güllüoğlu; Özlem Durmaz
Journal:  J Korean Med Sci       Date:  2013-09-25       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.